COM:CASTLEBIOSCIENCES
Castle Biosciences
- Stock
Last Close
28.88
22/11 21:00
Market Cap
482.57M
Beta: -
Volume Today
314.82K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|
average inventory | 593.40K - | 1.06M 78.57% | 1.73M 62.98% | 2.12M 22.70% | 3.00M 41.60% | 5.96M 98.67% | ||
average payables | 1.28M - | 1.66M 29.14% | 1.98M 19.52% | 2.32M 17.18% | 3.64M 56.70% | 7.50M 106.12% | ||
average receivables | 8.37M - | 13.37M 59.70% | 13.70M 2.50% | 15.02M 9.61% | 20.38M 35.67% | 30.89M 51.57% | ||
book value per share | -1.46 - | -0.95 35.18% | 9.92 1,148.77% | 21.96 121.48% | 16.38 25.41% | 15.32 6.47% | 14.60 4.71% | |
capex per share | -0.05 - | -0.03 48.57% | -0.11 319.64% | -0.25 129.94% | -0.14 44.79% | -0.22 56.01% | -0.51 135.10% | |
capex to depreciation | -1.59 - | -0.86 46.13% | -2.62 205.17% | -10.07 284.58% | -1.02 89.84% | -0.53 47.75% | -1.10 106.80% | |
capex to operating cash flow | 0.04 - | 0.02 44.29% | -0.13 692.77% | -0.48 260.56% | 0.18 138.10% | 0.14 26.31% | 2.42 1,690.66% | |
capex to revenue | -0.04 - | -0.01 66.21% | -0.02 48.59% | -0.08 319.76% | -0.04 51.18% | -0.04 11.02% | -0.06 50.79% | |
cash per share | 0.12 - | 0.42 239.44% | 11.52 2,638.40% | 21.65 88.03% | 13.11 39.44% | 9.93 24.30% | 9.07 8.63% | |
days of inventory on hand | 22.59 - | 60.79 169.15% | 61.77 1.60% | 83.55 35.27% | 46.62 44.20% | 45.38 2.66% | 64.44 42.00% | |
days payables outstanding | 82.82 - | 99.97 20.72% | 93.12 6.85% | 79.07 15.09% | 58.73 25.72% | 53.95 8.15% | 83.32 54.44% | |
days sales outstanding | 123.46 - | 193.66 56.86% | 103.09 46.77% | 74.34 27.89% | 67.05 9.81% | 62.53 6.74% | 63.61 1.73% | |
debt to assets | 1.89 - | 1.09 42.27% | 0.21 80.81% | 0.02 - | 0.03 70.36% | 0.03 13.50% | ||
debt to equity | -1.30 - | -2.43 86.66% | 0.30 112.13% | 0.02 - | 0.03 69.94% | 0.04 17.34% | ||
dividend yield | ||||||||
earnings yield | -0.06 - | -0.03 52.71% | 0.02 164.03% | -0.01 145.23% | -0.03 258.90% | -0.11 276.98% | -0.10 9.24% | |
enterprise value | 226.77M - | 247.94M 9.33% | 221.31M 10.74% | 861.23M 289.15% | 756.07M 12.21% | 503.67M 33.38% | 494.86M 1.75% | |
enterprise value over ebitda | -21.81 - | -65.91 202.27% | 43.69 166.29% | -151.17 445.98% | -20.66 86.34% | -6.57 68.18% | 46.58 808.74% | |
ev to operating cash flow | -18.54 - | -20.17 8.79% | 31.55 256.44% | 87.30 176.73% | -39.83 145.62% | -12.09 69.64% | -87.96 627.44% | |
ev to sales | 16.49 - | 10.88 34.00% | 4.27 60.79% | 13.75 222.17% | 8.04 41.54% | 3.68 54.26% | 2.25 38.74% | |
free cash flow per share | -1.30 - | -1.18 9.27% | 0.71 159.99% | 0.27 61.84% | -0.89 430.81% | -1.81 103.07% | -0.72 60.43% | |
free cash flow yield | -0.06 - | -0.06 9.27% | 0.02 137.35% | 0.00 80.47% | -0.02 618.17% | -0.08 269.83% | -0.03 56.84% | |
graham net net | -1.97 - | -1.74 11.72% | 8.83 608.83% | 20.97 137.39% | 11.65 44.45% | 8.83 24.19% | 7.97 9.69% | |
graham number | 6.44 - | 3.57 44.64% | 11.71 228.40% | 16.38 39.91% | 21.42 30.73% | 29.80 39.14% | 26.54 10.96% | |
income quality | 0.99 - | 1.93 95.24% | 1.33 31.16% | -0.96 172.16% | 0.61 163.24% | 0.62 2.27% | 0.10 84.22% | |
intangibles to total assets | 0.00 - | 0.00 95.45% | 0 100% | 0 | 0.19 Infinity% | 0.28 46.93% | 0.26 8.36% | |
interest coverage | -6.61 - | -1.69 74.47% | 1.03 161.05% | -2.48 341.19% | -40.08K 1,613,597.43% | -5.36K 86.62% | -965.73 81.99% | |
interest debt per share | 2.07 - | 2.51 21.45% | 3.46 37.60% | 0.14 95.98% | 0.32 131.00% | 0.51 59.13% | 0.57 11.59% | |
inventory turnover | 16.16 - | 6.00 62.85% | 5.91 1.57% | 4.37 26.08% | 7.83 79.21% | 8.04 2.73% | 5.66 29.58% | |
invested capital | -1.30 - | -2.43 86.66% | 0.30 112.13% | 0.02 - | 0.03 69.94% | 0.04 17.34% | ||
market cap | 209.38M - | 227.92M 8.85% | 295.03M 29.45% | 1.27B 330.83% | 1.08B 15.22% | 613.31M 43.09% | 578.39M 5.69% | |
net current asset value | -17.41M - | -14.35M 17.57% | 82.05M 671.84% | 405.96M 394.78% | 302.91M 25.38% | 244.11M 19.41% | 233.56M 4.32% | |
net debt to ebitda | -1.67 - | -5.32 218.29% | -14.56 173.46% | 71.94 594.26% | 8.78 87.79% | 1.43 83.71% | -7.86 649.60% | |
net income per share | -1.26 - | -0.60 52.71% | 0.61 202.83% | -0.54 188.38% | -1.24 129.13% | -2.58 107.00% | -2.14 16.79% | |
operating cash flow per share | -1.25 - | -1.15 7.68% | 0.82 170.79% | 0.52 36.23% | -0.76 244.90% | -1.60 111.71% | -0.21 86.87% | |
payables turnover | 4.41 - | 3.65 17.16% | 3.92 7.35% | 4.62 17.78% | 6.21 34.62% | 6.77 8.87% | 4.38 35.25% | |
receivables turnover | 2.96 - | 1.88 36.25% | 3.54 87.87% | 4.91 38.68% | 5.44 10.87% | 5.84 7.22% | 5.74 1.70% | |
research and ddevelopement to revenue | 0.33 - | 0.21 34.50% | 0.14 33.16% | 0.21 48.60% | 0.32 48.92% | 0.33 3.99% | 0.24 25.55% | |
return on tangible assets | -1.26 - | -0.28 77.53% | 0.04 115.50% | -0.02 153.12% | -0.08 257.76% | -0.21 149.76% | -0.17 18.23% | |
revenue per share | 1.41 - | 2.14 52.19% | 6.04 182.42% | 3.31 45.22% | 3.74 13.09% | 5.26 40.53% | 8.20 55.91% | |
roe | 0.87 - | 0.63 27.05% | 0.06 90.19% | -0.02 139.90% | -0.08 207.20% | -0.17 121.32% | -0.15 12.68% | |
roic | -2.52 - | -0.27 89.43% | 0.04 115.83% | -0.02 137.67% | -0.07 361.66% | -0.21 184.74% | 0.03 112.09% | |
sales general and administrative to revenue | 1.11 - | 0.72 34.84% | ||||||
shareholders equity per share | -1.46 - | -0.95 35.18% | 9.92 1,148.77% | 21.96 121.48% | 16.38 25.41% | 15.32 6.47% | 14.60 4.71% | |
stock based compensation to revenue | 0.01 - | 0.01 63.07% | 0.02 86.87% | 0.13 450.74% | 0.23 74.22% | 0.27 14.70% | 0.23 12.07% | |
tangible asset value | -14.31M - | -10.07M 29.61% | 85.11M 944.94% | 415.69M 388.40% | 322.82M 22.34% | 272.80M 15.49% | 273.93M 0.41% | |
tangible book value per share | -1.46 - | -0.95 35.34% | 9.92 1,148.33% | 21.96 121.48% | 12.84 41.52% | 10.47 18.47% | 14.60 39.42% | |
working capital | 1.46M - | 11.39M 678.14% | 101.39M 790.26% | 408.72M 303.11% | 328.86M 19.54% | 256.16M 22.11% | 247.97M 3.20% |
All numbers in USD (except ratios and percentages)